Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Hsiang Shih

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Immunology, Immunotherapy : CII|April 10, 2026
Comparative safety of PD-1 and PD-L1 inhibitors in advanced solid tumors: a real-world cohort study with competing risk analysisYu-Hsiang Shih, Shao-Jing Wang, Chun-Ting Fan, et al.
Comprehensive Psychiatry|November 27, 2025
Long-term risk of psychiatric disorders in women with endometriosis: A retrospective cohort studyYu-Hsiang Shih, Shao-Jing Wang, Chun-Ting Fan, et al.
BMC Medicine|February 21, 2025
A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcomaTing-Fang Lu, Lou Sun, Yu-Hsiang Shih, et al.
BMC Medicine|March 15, 2025
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancerShao-Jing Wang, Lou Sun, Yu-Hsiang Shih, et al.
Journal of Clinical Medicine|October 16, 2024
Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus PaclitaxelShao-Jing Wang, Hsin-Hua Chen, Lou Sun, et al.
Journal of Clinical Medicine|January 21, 2023
Improved Progression-Free Survival Associated with Tumor-Infiltrating Lymphocytes in High-Grade Endometrial CancerChun-Ting Fan, Shih-Tien Hsu, Lou Sun, et al.
Frontiers in Oncology|December 13, 2023
Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcomaSzu-Yun Niu, Lou Sun, Shih-Tien Hsu, et al.
Bioengineering & Translational Medicine|July 22, 2024
Evaluation of a novel vaginal cells self-sampling device for human papillomavirus testing in cervical cancer screening: A clinical trial assessing reliability and acceptabilityChung-Yao Yang, Ting-Chang Chang, Hung-Hsueh Chou, et al.
Journal of Medical Virology|February 29, 2024
Consistency in human papillomavirus type detection between self-collected vaginal specimens and physician-sampled cervical specimensHung-Hsueh Chou, Chung-Yao Yang, Angel Chao, et al.
Scientific Reports|July 24, 2024
Disparities in medical recommendations from AI-based chatbots across different countries/regionsKhanisyah E Gumilar, Birama R Indraprasta, Yu-Cheng Hsu, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Immunology, Immunotherapy : CII|April 10, 2026
Comparative safety of PD-1 and PD-L1 inhibitors in advanced solid tumors: a real-world cohort study with competing risk analysisYu-Hsiang Shih, Shao-Jing Wang, Chun-Ting Fan, et al.
Comprehensive Psychiatry|November 27, 2025
Long-term risk of psychiatric disorders in women with endometriosis: A retrospective cohort studyYu-Hsiang Shih, Shao-Jing Wang, Chun-Ting Fan, et al.
BMC Medicine|February 21, 2025
A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcomaTing-Fang Lu, Lou Sun, Yu-Hsiang Shih, et al.
BMC Medicine|March 15, 2025
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancerShao-Jing Wang, Lou Sun, Yu-Hsiang Shih, et al.
Journal of Clinical Medicine|October 16, 2024
Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus PaclitaxelShao-Jing Wang, Hsin-Hua Chen, Lou Sun, et al.
Journal of Clinical Medicine|January 21, 2023
Improved Progression-Free Survival Associated with Tumor-Infiltrating Lymphocytes in High-Grade Endometrial CancerChun-Ting Fan, Shih-Tien Hsu, Lou Sun, et al.
Frontiers in Oncology|December 13, 2023
Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcomaSzu-Yun Niu, Lou Sun, Shih-Tien Hsu, et al.
Bioengineering & Translational Medicine|July 22, 2024
Evaluation of a novel vaginal cells self-sampling device for human papillomavirus testing in cervical cancer screening: A clinical trial assessing reliability and acceptabilityChung-Yao Yang, Ting-Chang Chang, Hung-Hsueh Chou, et al.
Journal of Medical Virology|February 29, 2024
Consistency in human papillomavirus type detection between self-collected vaginal specimens and physician-sampled cervical specimensHung-Hsueh Chou, Chung-Yao Yang, Angel Chao, et al.
Scientific Reports|July 24, 2024
Disparities in medical recommendations from AI-based chatbots across different countries/regionsKhanisyah E Gumilar, Birama R Indraprasta, Yu-Cheng Hsu, et al.
Pageof 3